greeksoup/ stock research
Stock research / United States / Funds / Qvidtvm Management LLC

Qvidtvm Management LLC

CIK 1912226 · latest 13F filed 13 August 2026 · Read the filing on EDGAR

Qvidtvm Management LLC reported 14 US-listed holdings worth $76.6 million in its 13F for the quarter ended 30 June 2026, filed 13 August 2026. Its largest: Bio-Rad Laboratories, Inc. (25.4%), Yandex N V (17.5%) and Amrize Ltd. (17.2%). Against the quarter before, it opened 1 position, added to 3, trimmed 10 and sold out of 1.

Reported holdings$76.6M-5.9% on Q1 2026
Positions14as many as Q1 2026
The largest ten99.2%of its reported holdings
Latest 13FQ2 2026filed 13 August 2026
Where the money is
OpenedAdded toTrimmed
BIO25.4%NBIS17.5%AMRZ17.2%ORCL10.9%SOLV9.0%ZGN7.7%ARE5.7%BRCC4.3%OCTV1.2%

The 14 largest of its 14 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $142.9 million in 8 positions$143MQ3 24Q4 2024: $124.2 million in 8 positions$124MQ4 24Q1 2025: $113.1 million in 8 positions$113MQ1 25Q2 2025: $99.8 million in 8 positions$99.8MQ2 25Q3 2025: $92.9 million in 8 positions$92.9MQ3 25Q4 2025: $88.4 million in 13 positions$88.4MQ4 25Q1 2026: $81.4 million in 14 positions$81.4MQ1 26Q2 2026: $76.6 million in 14 positions$76.6MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +11.6% over the 2 quarters to 30 June 2026, against +9.5% for the S&P 500.

Its reported holdingsThe S&P 500
95100105110Q4 25Q1 26Q2 26Its holdings +11.6%S&P 500 +9.5%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 1Added 3Trimmed 10Sold out 1
Opened: 1Added: 3Trimmed: 10Sold out: 1

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 1

  1. Octave Intelligence PLC Ord SHS Class B OCTV$936,696

Added to 3

  1. Oracle Corp. ORCL+18,068 shares · +46%
  2. Alexandria Real Estate Equities, Inc. ARE+42,470 shares · +106%
  3. Amrize Ltd. AMRZ+29,935 shares · +14%

Trimmed 10

  1. Solventum Corp. SOLV-176,582 shares · -66%
  2. Bio-Rad Laboratories, Inc. BIO-17,489 shares · -21%
  3. Dentsply Sirona Inc. XRAY-366,480 shares · -95%
  4. Yandex N V NBIS-12,021 shares · -20%
  5. Ermenegildo Zegna N V ZGN-70,089 shares · -13%
  6. H&R Block Inc. HRB-22,411 shares · -96%
  7. Westinghouse Air Brake Technologies Corp. WAB-2,020 shares · -73%
  8. BRC Inc. BRCC-447,543 shares · -13%

and 2 more in the table below

Sold out of 1

  1. Rentokil Initial PLC RTO$216,551 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Bio-Rad Laboratories, Inc. BIO66.2K$19.4 million25.39%-17.5K
Yandex N V NBIS48.7K$13.4 million17.54%-12.0K
Amrize Ltd. AMRZ247.4K$13.2 million17.21%+29.9K
Oracle Corp. ORCL57.0K$8.3 million10.90%+18.1K
Solventum Corp. SOLV89.0K$6.9 million8.97%-176.6K
Ermenegildo Zegna N V ZGN455.8K$5.9 million7.75%-70.1K
Alexandria Real Estate Equities, Inc. ARE82.5K$4.4 million5.69%+42.5K
BRC Inc. BRCC3.0M$3.3 million4.28%-447.5K
Octave Intelligence PLC Ord SHS Class B OCTV57.5K$936,6961.22%new
Westinghouse Air Brake Technologies Corp. WAB750$202,2000.26%-2.0K
Dentsply Sirona Inc. XRAY18.9K$200,8370.26%-366.5K
Philip Morris International Inc. PM1.0K$185,6140.24%-53
Standard Biotools Inc. LAB222.0K$182,6390.24%-7.3K
H&R Block Inc. HRB844$32,1400.04%-22.4K
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 1 it sold out of are in the box above.